UPLOAD Filing
VOLITIONRX LTD
Date: Feb. 13, 2026 · CIK: 0000093314 · Accession: 0000000000-26-001589
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293314
Letter
Re: VolitionRx Limited Registration Statement on Form S-3 Filed February 09, 2026 File No. 333-293314 Dear Cameron Reynolds:
February 13, 2026
Cameron Reynolds Chief Executive Officer VolitionRx Limited 1489 West Warm Springs Road, Suite 110 Henderson, NV 89014
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Marc G. Alcser, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> February 13, 2026 Cameron Reynolds Chief Executive Officer VolitionRx Limited 1489 West Warm Springs Road, Suite 110 Henderson, NV 89014 Re: VolitionRx Limited Registration Statement on Form S-3 Filed February 09, 2026 File No. 333-293314 Dear Cameron Reynolds: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Marc G. Alcser, Esq. </TEXT> </DOCUMENT>